Retina Associates of Orange County

What Retina Associates of Orange County does

Retina Associates of Orange County is a private, physician-owned medical practice group established in 2008 in Orange County, California, specializing in the diagnosis and treatment of sight-threatening retinal and vitreoretinal conditions. The group operates across three clinical locations — Laguna Hills, Santa Ana, and Newport Beach — staffed by five board-certified ophthalmologists who are all fellowship-trained in vitreoretinal surgery, with training pedigrees from leading academic centers including Bascom Palmer Eye Institute, Harvard/Mass Eye & Ear, Oxford/Moorfields, Columbia, USC Doheny, Weill Cornell, and Duke. Clinical services span the major retinal disease categories: age-related macular degeneration (wet and dry/geographic atrophy), diabetic retinopathy and diabetic macular edema, retinal tears and detachments, macular pucker/epiretinal membrane, and retinal vein occlusion.

The practice's care delivery is grounded in conventional vitreoretenal diagnostic and surgical technology: optical coherence tomography (OCT) and fluorescein angiography for non-invasive and dye-based retinal imaging; anti-VEGF intravitreal injections (Lucentis, Eylea, Eylea HD, Pavblu, Vabysmo, Avastin) and emerging agents (Syfovre, Izervay) for wet AMD, geographic atrophy, and macular edema; and micro-incisional surgical procedures including pars plana vitrectomy, scleral buckle surgery, pneumatic retinopexy, and laser photocoagulation. The affiliated Retina Associates Research Institute & Clinical Trial Network provides a sponsored-research layer, running Phase 1–4 trials across multiple pharmaceutical partners and giving the practice early access to investigational therapeutics.

The business model is a fee-for-service professional medical practice billed through commercial insurance, Medicare, and Medicaid, with patient responsibility collected at time of service. The go-to-market is reputation- and referral-driven: physician-to-physician referrals from PCPs and general ophthalmologists, direct patient self-referrals, and location-targeted organic SEO/content marketing (educational website content, condition-specific pages, and patient testimonials). Patient acquisition is supported by multilingual staff covering English, Spanish, Chinese, Korean, Vietnamese, Tagalog, and Farsi to serve Orange County's diverse demographic mix. Hospital affiliation with Orange County Global Medical Center (Dr. McGuire as Chief of Ophthalmology) provides surgical channel access and emergency call coverage beyond the outpatient office footprint.

Name

Retina Associates of Orange County

Legal name

Retina Associates of Orange County

Website

https://retinaorangecounty.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Retina Associates of Orange County is a private physician-owned group of five fellowship-trained vitreoretinal surgeons diagnosing and treating sight-threatening retinal conditions, including AMD, diabetic retinopathy, and retinal detachments, across three Orange County, California clinic locations.

Ownership category

akta.pro rank

Product category

Ophthalmology / Vitreoretinal Surgery Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC), Ophthalmology Surgery Centers (HLAFAIAF)

Keywords

• Vitreoretinal surgery
• Retinal disease treatment
• Macular degeneration care
• Diabetic retinopathy treatment
• Ophthalmology services

Headquarters

HQ city

Laguna Hills

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive retinal care services including office consultations, diagnostic imaging (OCT, fluorescein angiography), intravitreal injections, laser treatments, and surgical procedures (vitrectomy, scleral buckle). Services are billed to insurance including Medicare and Medicaid, with patient responsibility portions collected at time of service.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Retina Associates of Orange County is a private medical practice delivering specialized vitreoretinal care through consultations, advanced diagnostic imaging (OCT, fluorescein angiography), in-office anti-VEGF intravitreal injections, laser photocoagulation, and vitreoretinal surgery (vitrectomy, scleral buckle, pneumatic retinopexy) for patients with sight-threatening retinal diseases. The practice also conducts clinical trial research through the Retina Associates Research Institute & Clinical Trial Network, providing patients access to investigational retinal therapies.

Product overview

Retina Associates of Orange County is a medical practice offering specialized ophthalmology and vitreoretinal surgery services. The practice provides diagnostic and treatment services for retinal conditions including age-related macular degeneration (AMD), diabetic retinopathy, macular pucker, retinal tears and detachments, and retinal vein occlusion. Services include micro-incisional vitrectomy, anti-VEGF injections (Lucentis, Eylea, Avastin), laser photocoagulation, and surgical procedures. The practice operates three office locations in Orange County, California (Laguna Hills, Santa Ana, Newport Beach) and offers clinical trials research. No standalone software products or modules are offered.

Differentiator

Problem solved

Functional benefit

Brands

• Retina Associates Research Institute & Clinical Trial Network: A clinical trial network conducting research studies for retinal conditions including neovascular AMD, diabetic macular edema, retinal vein occlusion, and vitreomacular adhesion.

Products and services

• Age-Related Macular Degeneration (AMD) Treatment

Quantifiable outcome

• Treatment of wet AMD with anti-VEGF injections can reduce risk of further vision loss and may improve vision in some patients
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

26 partnerships are on record, tiered minor and core.

• Graybug VisionminorStrategic or Co-development Partner · 1 January 2019Clinical trial partnership evaluating GB-102 (intravitreal depot formulation of sunitinib malate) for treatment of neovascular age-related macular degeneration. Phase 1/2 multicenter study assessing safety and efficacy of repeated intravitreal injections.
• Clearside Biomedical (TOPAZ Trial)minorStrategic or Co-development Partner · 1 January 2019Completed clinical trial evaluating suprachoroidal CLS-TA in combination with intravitreal anti-VEGF agent for treatment of retinal vein occlusion, demonstrating superior efficacy compared to anti-VEGF monotherapy.
• Allergan (Sequoia Trial)minorStrategic or Co-development Partner · 1 January 2019Completed clinical trial participation in Allergan-sponsored ophthalmology research studies.
• Hoffmann-La Roche (BOULEVARD Trial)minorStrategic or Co-development Partner · 1 January 2019Completed Phase 2 study of RO6867461 (faricimab) in participants with center-involving diabetic macular edema (CI-DME), comparing efficacy and safety against ranibizumab.
• Iconic TherapeuticsminorStrategic or Co-development Partner · 1 January 2019Clinical trial participation evaluating hI-con1 for treatment of choroidal neovascularization secondary to age-related macular degeneration (EMERGE study).
• ThromboGenics (ORBIT Trial)minorStrategic or Co-development Partner · 1 January 2019Completed observational Phase 4 study of JETREA (ocriplasmin) for treatment of symptomatic vitreomacular adhesion in real-world setting, assessing anatomical and functional outcomes across approximately 120 USA retina sites.
• Kato PharmaceuticalsminorStrategic or Co-development Partner · 1 January 2019Completed study of Resolvine injection for treatment of vitreomacular attachment, investigating effects on patients with this condition.
• PfizerminorStrategic or Co-development Partner · 1 January 2019Completed Phase 2 study evaluating CCR2/5 receptor antagonist for diabetic macular edema, exploring oral drug alternative to intravitreal injections.
• Lpath Inc. (NEXUS Trial)minorStrategic or Co-development Partner · 1 January 2019Completed study of iSONEP (anti-sphingolipid mAb) with and without Lucentis/Avastin/Eylea for wet AMD treatment, evaluating anti-permeability, anti-angiogenic, anti-inflammatory, and anti-fibrotic properties.
• Ohr Pharmaceutical Inc.minorStrategic or Co-development Partner · 1 January 2019Completed clinical trial participation in ophthalmology research studies sponsored by Ohr Pharmaceutical.
• Orange County Global Medical CentercoreOthers · 1 January 2019Dr. Desmond McGuire serves as Chief of Ophthalmology at Orange County Global Medical Center in Santa Ana, providing hospital-based retinal care and emergency services.
• American Academy of OphthalmologyminorOthersProfessional membership organization providing continuing education, clinical guidelines, and advocacy for ophthalmologists. Affiliated institution for all physicians.
• American Society of Retina Specialists (ASRS)minorOthersProfessional society for retina specialists. Dr. Mrinali Gupta serves on the ASRS Board of Directors and Co-Chair of Early Career Section. Primary professional affiliation for the practice's retina specialists.
• Harvard Medical School / Mass Eye & Ear InfirmaryminorOthersTraining affiliation institution for Dr. Mrinali Gupta's ophthalmology residency. Prestigious academic medical center providing fellowship-level training in vitreoretinal diseases and surgery.
• Weill Cornell Medical College / NewYork-Presbyterian HospitalminorOthersTraining affiliation for Dr. Gupta's 2-year Vitreoretinal Diseases & Surgery fellowship. Dr. Gupta previously served as Assistant Professor and Director of Medical Retina Fellowship Program at Weill Cornell.
• Duke University School of MedicineminorOthersMedical school affiliation for Dr. Mrinali Gupta. Duke is a top-ranked medical institution where Dr. Gupta received her MD and was elected to Alpha Omega Alpha honor society.
• Columbia University College of Physicians and SurgeonsminorOthersMedical school and residency training affiliation for Dr. John Hwang. Dr. Hwang holds both MD and MBA from Columbia University and completed residency at Edward S. Harkness Eye Institute at Columbia.
• Bascom Palmer Eye InstituteminorOthersTraining affiliation for Dr. Charles Eifrig's residency and fellowship. Widely regarded as the #1 eye hospital in the United States. Dr. Eifrig directed Ocular Trauma and Emergency Services during fellowship.
• Oxford UniversityminorOthersMedical school and fellowship training affiliation for Dr. John S. Lean. Dr. Lean received his MD at New College, Oxford University and completed vitreoretinal fellowship at Moorfields Eye Hospital in London.
• Doheny Eye Institute / USCminorOthersTraining affiliation for Dr. Hwang (fellowship) and Dr. Lean (Associate Professor tenure 1982-1990). Doheny Eye Institute is a leading retina research and training center affiliated with University of Southern California.
• Shiley Eye Center / UC San DiegominorOthersTraining affiliation for Dr. McGuire's vitreoretinal fellowship (2003). Dr. McGuire was named Teacher of the Year during fellowship at this prestigious UC San Diego eye center.
• Moorfields Eye HospitalminorOthersTraining affiliation for Dr. John S. Lean's ophthalmology residency and vitreoretinal fellowship. World-renowned eye hospital in London, England.
• Sackler School of Medicine / Tel Aviv UniversityminorOthersMedical school affiliation for Dr. Desmond McGuire's MD degree through the New York State/American Program.
• Memorial Sloan-Kettering Cancer CenterminorOthersInternship training affiliation for Dr. Mrinali Gupta. Premier cancer treatment center in New York City where Dr. Gupta completed her medical internship.
• University of North Carolina, Chapel HillminorOthersMedical school affiliation for Dr. Charles Eifrig's MD degree. Dr. Eifrig received academic merit award for scholastic achievement and excellence in ophthalmic research.
• Carolina Hurricanes (NHL)minorOthersDr. Charles Eifrig served as Team Eye Surgeon for the Carolina Hurricanes of the National Hockey League from 2005-2008, providing ophthalmologic care to professional athletes.

Scale indicators4 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Wills Eye Hospital: Major academic ophthalmology specialty hospital in Philadelphia providing full-spectrum eye care including vitreoretinal surgery. Comparable as a benchmark for clinical research activity and complex retinal case management, though operating under a hospital model rather than independent specialty practice.
• Retina Consultants of America: PE-backed ( Webster Equity Partners ) platform aggregating retina specialist practices across the U.S. Operates as a broad incumbent consolidating independent retina groups; directly comparable service line (AMD, DME, retinal detachment surgery) under a multi-practice ownership model.
• Bascom Palmer Eye Institute: Nationally ranked academic eye hospital where multiple RAOC physicians trained. Operates a broader ophthalmology service line including vitreoretinal surgery, providing academic-practice benchmark for clinical excellence and clinical trial activity.

Direct peers

• Retina Vitreous Associates Medical Group: Long-standing Southern California retina specialty practice with multiple locations in the Los Angeles area offering anti-VEGF injections, vitrectomy, and laser retinal care. Direct regional competitive peer targeting the same patient segments in an adjacent Southern California market.
• Associated Retinal Consultants: Large multi-physician retina specialty practice in Michigan with fellowship-trained vitreoretinal surgeons. Comparable specialty group model focused exclusively on retinal disease treatment and surgery.
• Texas Retina Associates: Multi-physician retinal specialty practice in Texas offering comprehensive vitreoretinal medical and surgical care, with active clinical research program. Comparable physician-owned specialty group model with fellowship-trained surgeons.
• Mid Atlantic Retina: Large specialty vitreoretinal practice with multiple locations in the Mid-Atlantic region, part of the Retina Consultants of America platform. Directly comparable in physician scale, subspecialty focus, and clinical research involvement.
• California Retina Consultants: Multi-location retinal specialty practice serving Southern California with fellowship-trained vitreoretinal surgeons. Direct competitive peer in the same California market offering AMD, diabetic retinopathy, and retinal detachment treatment.
• Orange County Retina Medical Group: Local competitor retina practice operating in the same Orange County market with fellowship-trained vitreoretinal surgeons. Head-to-head competitor for retinal disease referrals and physician brand competition within the same service area.

Regional players

• New England Retina Associates: Multi-physician retinal specialty practice in the Northeast offering similar vitreoretinal medical and surgical services. Comparable operating model (fellowship-trained retinal surgeons, multi-location) but operating in a different geographic market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Associates of Orange County